Skip to main content
Finolex Industries Ltd. logo

Finolex Industries Ltd. — Investor Relations & Filings

Ticker · FINPIPE ISIN · INE183A01024 LEI · 335800DLFD2ERNKIDE17 BSE.NS Manufacturing
Open in API
Filings indexed 1,864 across all filing types
Latest filing 2022-11-14 Regulatory Filings
Country IN India
Listing BSE.NS FINPIPE

About Finolex Industries Ltd.

https://www.finolexpipes.com/

Finolex Industries Ltd. is a manufacturer of polyvinyl chloride (PVC) pipes and fittings, as well as PVC resin. The company operates a backward-integrated manufacturing model, producing its own PVC resin to ensure quality control and supply consistency for its downstream pipe production. Its product portfolio includes a comprehensive range of PVC-U pipes and fittings designed for applications in agriculture, plumbing, and sanitation. These products support irrigation systems, borewells, and residential and commercial water management. With multiple manufacturing facilities and an extensive distribution network, the company provides fluid management solutions across various sectors. It is characterized by its focus on high-quality standards and technological integration, offering durable products for water transportation and infrastructure development.

Recent filings

Filing Released Lang Actions
Investor Presentation
Regulatory Filings Classification · 95% confidence The document is a short communication dated 14th November 2022 addressed to stock exchanges regarding the outcome of an investors/analysts meeting. It explicitly states that no presentation or unpublished price sensitive information was discussed, only a company overview. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The length is only 1541 characters, indicating it is a brief announcement rather than a detailed report. There is no financial data, no detailed presentation, or transcript included. This fits the profile of a Regulatory Filing (RNS) as it is a general regulatory announcement about an event without substantive financial or strategic content. It is not an Investor Presentation (IP) because no presentation was made or attached, nor is it a Call Transcript (CT) since it is not a transcript. It is not a Report Publication Announcement (RPA) because it does not mention any report being published or attached.
2022-11-14 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges about scheduled analyst/investor meetings with the company's management. It references Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information. The content is an announcement of upcoming investor interactions, not the actual investor presentation or detailed financial report. The document length is only 1595 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under the category of Investor Presentation (IP) announcements or related notices. However, since it is only an intimation of meetings and not the presentation itself, and given the options, the closest and most appropriate classification is Regulatory Filings (RNS) as a general regulatory announcement about investor meetings.
2022-11-14 English
Intimation of Analyst/Investors meet/ Interaction as per the schedule provided in the attached letter.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying about scheduled analyst/investor meetings with the company's management. It references Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information. The content is an announcement of upcoming investor interactions, not a report or transcript of the meetings themselves. The document length is short (1594 characters), and it does not contain financial data, management discussion, or detailed presentations. Therefore, it is best classified as a Regulatory Filing (RNS) since it is a general regulatory announcement about investor meetings and does not fit other specific categories like Investor Presentation or Call Transcript, which would require actual content of the meetings or presentations.
2022-11-14 English
OUTCOME OF ANALYST INVESTOR MEET ON 9TH NOVEMBER, 2022. COPY OF LETTER ATTACHED.
Regulatory Filings Classification · 95% confidence The document is a short communication addressed to stock exchanges regarding the outcome of an investors/analysts meeting held on 9th November 2022. It explicitly states that no presentation was made and no unpublished price sensitive information was discussed. The document references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is an announcement of the meeting outcome rather than a detailed report or transcript. The document length is only 1819 characters, indicating it is brief and informational. Therefore, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement category for such disclosures that do not fit other specific categories like Call Transcript or Investor Presentation.
2022-11-09 English
Investor Presentation
Regulatory Filings Classification · 95% confidence The document is a short announcement dated 9th November 2022, addressed to stock exchanges, reporting the outcome of an investors/analysts meeting. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content states that company officials interacted with an investor via virtual conference, no presentation was made, and no unpublished price sensitive information was discussed. The document is brief (1815 characters) and serves as a notification of the meeting outcome rather than a detailed report or transcript. It does not contain financial data, detailed analysis, or a transcript of the call. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2022-11-09 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a short notice dated 9th November 2022 addressed to stock exchanges regarding an upcoming Analyst/Investor meet scheduled as a virtual conference. It references Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of events or information. The document does not contain any financial data, detailed presentation, or report content. It is an announcement informing the exchanges and public about the scheduled investor interaction. The document length is only 1689 characters, which is quite short and consistent with an announcement rather than a full report or transcript. Therefore, this document fits best under Regulatory Filings (RNS) as a general regulatory announcement about an investor meeting, not an investor presentation (IP) or call transcript (CT).
2022-11-09 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.